Kupffer-cell-expressed transmembrane TNF-α is a major contributor to lipopolysaccharide and D-galactosamine-induced liver injury

Peng Yang,Wenjing Zhou,Chenxi Li,Meng Zhang,Yaping Jiang,Rui Jiang,Hongping Ba,Cheng Li,Jing Wang,Bingjiao Yin,Feili Gong,Zhuoya Li
DOI: https://doi.org/10.1007/s00441-015-2252-2
2015-01-01
Cell and Tissue Research
Abstract:Tumor necrosis factor (TNF)-α exists in two bioactive forms, a 26-kDa transmembrane form (tmTNF-α) and a 17-kDa soluble form (sTNF-α). sTNF-α has been recognized as a key regulator of hepatitis; however, serum sTNF-α disappears in mice during the development of severe liver injury, and high levels of serum sTNF-α do not necessarily result in liver damage. Interestingly, in a mouse model of acute hepatitis, we have found that tmTNF-α expression on Kupffer cells (KCs) significantly increases when mice develop severe liver injury caused by lipopolysaccharide (LPS)/D-galactosamine (D-gal), and the level of tmTNF-α expression is positively related to the activity of serum transaminases. Therefore, we hypothesized that KC-expressed tmTNF-α constitutes a pathomechanism in hepatitis and have explored the role of tmTNF-α in this disease model. Here, we have compared the impact of KCs tmTNFlow and KCs tmTNFhigh on acute hepatitis in vivo and ex vivo and have further demonstrated that KCs tmTNFhigh , rather than KCs tmTNFlow , not only exhibit an imbalance in secretion of pro- and anti-inflammatory cytokines, favoring inflammatory response and exacerbating liver injury, but also induce hepatocellular apoptosis via tmTNF-α and the expression of another pro-apoptotic factor, Fas ligand. Our data suggest that KC tmTNFhigh is a major contributor to liver injury in LPS/D-gal-induced hepatitis.
What problem does this paper attempt to address?